 Vikhyat Bebarta
Concepts (622)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antidotes | 37 | 2025 | 143 | 13.420 |
Why?
| | Military Personnel | 51 | 2024 | 544 | 9.820 |
Why?
| | Cyanides | 28 | 2025 | 52 | 8.540 |
Why?
| | Wounds and Injuries | 37 | 2025 | 755 | 7.300 |
Why?
| | Hydroxocobalamin | 17 | 2020 | 26 | 6.810 |
Why?
| | Emergency Medical Services | 33 | 2025 | 547 | 6.660 |
Why?
| | Air Ambulances | 15 | 2024 | 32 | 4.270 |
Why?
| | Resuscitation | 15 | 2024 | 250 | 4.020 |
Why?
| | Afghan Campaign 2001- | 31 | 2024 | 132 | 3.820 |
Why?
| | Swine | 39 | 2025 | 773 | 3.800 |
Why?
| | Potassium Cyanide | 9 | 2025 | 21 | 3.690 |
Why?
| | Military Medicine | 15 | 2022 | 63 | 3.640 |
Why?
| | Cobamides | 8 | 2022 | 20 | 3.530 |
Why?
| | Poisoning | 10 | 2025 | 116 | 3.380 |
Why?
| | Thiosulfates | 8 | 2021 | 19 | 3.110 |
Why?
| | Hydrogen Sulfide | 7 | 2022 | 44 | 2.880 |
Why?
| | Intubation, Intratracheal | 11 | 2025 | 257 | 2.810 |
Why?
| | Infusions, Intraosseous | 10 | 2024 | 17 | 2.650 |
Why?
| | Sulfides | 8 | 2025 | 99 | 2.550 |
Why?
| | Laryngoscopes | 5 | 2025 | 38 | 2.470 |
Why?
| | Hypotension | 11 | 2021 | 122 | 2.410 |
Why?
| | Warfare | 13 | 2023 | 68 | 2.370 |
Why?
| | Critical Care | 12 | 2024 | 583 | 2.300 |
Why?
| | Apnea | 5 | 2020 | 21 | 2.250 |
Why?
| | Hospitals, Military | 9 | 2018 | 25 | 2.220 |
Why?
| | Emergency Medicine | 10 | 2018 | 226 | 2.150 |
Why?
| | Airway Management | 5 | 2019 | 52 | 2.020 |
Why?
| | Heart Arrest | 8 | 2024 | 338 | 1.970 |
Why?
| | Hydrocodone | 5 | 2019 | 17 | 1.950 |
Why?
| | Emergency Service, Hospital | 17 | 2024 | 2046 | 1.910 |
Why?
| | Analgesics, Opioid | 15 | 2020 | 992 | 1.890 |
Why?
| | Iraq War, 2003-2011 | 19 | 2024 | 127 | 1.890 |
Why?
| | Disease Models, Animal | 29 | 2025 | 4282 | 1.870 |
Why?
| | Laryngoscopy | 6 | 2025 | 109 | 1.840 |
Why?
| | Hemorrhage | 11 | 2025 | 721 | 1.810 |
Why?
| | Afghanistan | 16 | 2024 | 71 | 1.620 |
Why?
| | Analgesics | 5 | 2024 | 205 | 1.610 |
Why?
| | Antidepressive Agents, Tricyclic | 6 | 2014 | 30 | 1.550 |
Why?
| | Transportation of Patients | 3 | 2018 | 54 | 1.540 |
Why?
| | Ketamine | 6 | 2024 | 93 | 1.520 |
Why?
| | Critical Illness | 12 | 2025 | 804 | 1.500 |
Why?
| | Humans | 172 | 2025 | 136768 | 1.490 |
Why?
| | Mass Casualty Incidents | 7 | 2022 | 38 | 1.480 |
Why?
| | Shock, Hemorrhagic | 6 | 2024 | 167 | 1.460 |
Why?
| | Brain Injuries, Traumatic | 6 | 2023 | 355 | 1.440 |
Why?
| | Injury Severity Score | 16 | 2024 | 521 | 1.380 |
Why?
| | Male | 101 | 2025 | 67311 | 1.350 |
Why?
| | Prospective Studies | 32 | 2025 | 7572 | 1.340 |
Why?
| | Female | 97 | 2025 | 72796 | 1.330 |
Why?
| | Cardiopulmonary Resuscitation | 5 | 2020 | 249 | 1.290 |
Why?
| | Sulfhydryl Compounds | 5 | 2022 | 189 | 1.290 |
Why?
| | Airway Obstruction | 3 | 2018 | 162 | 1.270 |
Why?
| | Animals | 65 | 2025 | 36847 | 1.270 |
Why?
| | Heart Massage | 3 | 2019 | 7 | 1.250 |
Why?
| | Research | 6 | 2022 | 448 | 1.230 |
Why?
| | Toxicology | 4 | 2018 | 46 | 1.210 |
Why?
| | Retrospective Studies | 43 | 2024 | 15504 | 1.200 |
Why?
| | Drug Overdose | 10 | 2016 | 345 | 1.190 |
Why?
| | Pressure | 2 | 2020 | 221 | 1.170 |
Why?
| | Adult | 69 | 2025 | 37630 | 1.170 |
Why?
| | Poison Control Centers | 8 | 2017 | 90 | 1.140 |
Why?
| | Patient Transfer | 3 | 2019 | 168 | 1.130 |
Why?
| | Registries | 19 | 2024 | 2015 | 1.120 |
Why?
| | Blood Transfusion | 8 | 2025 | 323 | 1.100 |
Why?
| | Brugada Syndrome | 4 | 2008 | 10 | 1.100 |
Why?
| | Acute Pain | 3 | 2024 | 49 | 1.070 |
Why?
| | Respiration, Artificial | 6 | 2023 | 642 | 1.060 |
Why?
| | Opioid-Related Disorders | 7 | 2019 | 509 | 1.050 |
Why?
| | Amitriptyline | 4 | 2011 | 21 | 1.040 |
Why?
| | Injections, Intramuscular | 8 | 2024 | 126 | 1.000 |
Why?
| | Sodium Nitrite | 4 | 2016 | 39 | 1.000 |
Why?
| | Pain Measurement | 3 | 2018 | 521 | 0.980 |
Why?
| | Random Allocation | 7 | 2020 | 353 | 0.980 |
Why?
| | Sodium Bicarbonate | 6 | 2016 | 45 | 0.970 |
Why?
| | United States | 41 | 2024 | 14691 | 0.960 |
Why?
| | Hydrogen Cyanide | 3 | 2022 | 5 | 0.960 |
Why?
| | Pain Management | 5 | 2024 | 347 | 0.940 |
Why?
| | War-Related Injuries | 3 | 2021 | 9 | 0.940 |
Why?
| | Wounds, Penetrating | 3 | 2023 | 65 | 0.930 |
Why?
| | Craniocerebral Trauma | 2 | 2020 | 167 | 0.930 |
Why?
| | Hydromorphone | 3 | 2016 | 9 | 0.930 |
Why?
| | Substance Abuse Detection | 4 | 2019 | 87 | 0.920 |
Why?
| | Hemodynamics | 11 | 2023 | 1110 | 0.900 |
Why?
| | Heart Ventricles | 3 | 2020 | 785 | 0.890 |
Why?
| | Remote Consultation | 2 | 2015 | 50 | 0.870 |
Why?
| | Sus scrofa | 8 | 2024 | 52 | 0.860 |
Why?
| | Balloon Occlusion | 2 | 2024 | 34 | 0.860 |
Why?
| | Oxygen Inhalation Therapy | 5 | 2025 | 157 | 0.850 |
Why?
| | Wounds, Gunshot | 3 | 2022 | 220 | 0.850 |
Why?
| | Snake Bites | 5 | 2019 | 29 | 0.850 |
Why?
| | Freeze Drying | 1 | 2024 | 84 | 0.840 |
Why?
| | Blood Pressure | 10 | 2018 | 1774 | 0.830 |
Why?
| | Tetrathionic Acid | 2 | 2021 | 4 | 0.810 |
Why?
| | Chromatography, Liquid | 4 | 2022 | 433 | 0.810 |
Why?
| | Time Factors | 15 | 2024 | 6808 | 0.810 |
Why?
| | Plasma | 2 | 2024 | 212 | 0.810 |
Why?
| | Burns | 5 | 2025 | 325 | 0.810 |
Why?
| | Tandem Mass Spectrometry | 5 | 2022 | 532 | 0.780 |
Why?
| | Environmental Exposure | 4 | 2019 | 572 | 0.780 |
Why?
| | Internship and Residency | 4 | 2016 | 1132 | 0.760 |
Why?
| | Compartment Syndromes | 1 | 2022 | 25 | 0.740 |
Why?
| | Trauma Centers | 6 | 2025 | 419 | 0.730 |
Why?
| | Aorta | 2 | 2024 | 417 | 0.730 |
Why?
| | Acetylcysteine | 2 | 2014 | 145 | 0.720 |
Why?
| | Saline Solution, Hypertonic | 2 | 2014 | 41 | 0.720 |
Why?
| | Iraq | 9 | 2023 | 53 | 0.710 |
Why?
| | Administration, Intravenous | 5 | 2019 | 155 | 0.710 |
Why?
| | Pain | 5 | 2018 | 754 | 0.700 |
Why?
| | Young Adult | 28 | 2021 | 13129 | 0.700 |
Why?
| | Epinephrine | 5 | 2022 | 139 | 0.690 |
Why?
| | Acetaminophen | 3 | 2014 | 266 | 0.680 |
Why?
| | Patient Handoff | 1 | 2020 | 32 | 0.670 |
Why?
| | Blast Injuries | 6 | 2021 | 48 | 0.670 |
Why?
| | Morphine | 3 | 2017 | 158 | 0.660 |
Why?
| | Thorax | 1 | 2020 | 49 | 0.660 |
Why?
| | Thiadiazoles | 1 | 2020 | 23 | 0.650 |
Why?
| | Cannabinoids | 2 | 2012 | 161 | 0.650 |
Why?
| | Oxygen | 6 | 2025 | 930 | 0.640 |
Why?
| | Administration, Oral | 6 | 2021 | 813 | 0.640 |
Why?
| | Firearms | 3 | 2022 | 376 | 0.630 |
Why?
| | Chemically-Induced Disorders | 1 | 2019 | 2 | 0.630 |
Why?
| | Antivenins | 4 | 2013 | 36 | 0.630 |
Why?
| | Infusions, Intravenous | 8 | 2020 | 412 | 0.630 |
Why?
| | Hydroxyethyl Starch Derivatives | 1 | 2018 | 9 | 0.610 |
Why?
| | Humerus | 3 | 2022 | 39 | 0.590 |
Why?
| | Amputation, Traumatic | 1 | 2018 | 20 | 0.580 |
Why?
| | Glycine | 1 | 2019 | 175 | 0.580 |
Why?
| | Nursing Care | 1 | 2018 | 41 | 0.580 |
Why?
| | Norepinephrine | 1 | 2019 | 204 | 0.580 |
Why?
| | Ventricular Fibrillation | 1 | 2018 | 60 | 0.580 |
Why?
| | Cricoid Cartilage | 2 | 2015 | 17 | 0.570 |
Why?
| | Preceptorship | 1 | 2018 | 65 | 0.570 |
Why?
| | Emergency Treatment | 4 | 2018 | 118 | 0.570 |
Why?
| | Military Facilities | 1 | 2017 | 3 | 0.570 |
Why?
| | Monitoring, Physiologic | 7 | 2021 | 267 | 0.560 |
Why?
| | Tablets | 1 | 2017 | 40 | 0.560 |
Why?
| | Hypocalcemia | 3 | 2023 | 27 | 0.560 |
Why?
| | Hyperoxia | 4 | 2023 | 90 | 0.550 |
Why?
| | Chronic Pain | 3 | 2020 | 259 | 0.550 |
Why?
| | Fellowships and Scholarships | 3 | 2016 | 303 | 0.550 |
Why?
| | Cardiovascular Agents | 1 | 2019 | 159 | 0.540 |
Why?
| | Evidence-Based Emergency Medicine | 2 | 2016 | 3 | 0.540 |
Why?
| | Middle Aged | 33 | 2025 | 33228 | 0.530 |
Why?
| | Treatment Outcome | 17 | 2025 | 10744 | 0.530 |
Why?
| | Gas Poisoning | 1 | 2016 | 4 | 0.520 |
Why?
| | Oseltamivir | 1 | 2016 | 12 | 0.520 |
Why?
| | Tourniquets | 3 | 2021 | 24 | 0.510 |
Why?
| | Emergency Medical Technicians | 1 | 2016 | 36 | 0.510 |
Why?
| | Abdominal Pain | 2 | 2019 | 145 | 0.510 |
Why?
| | Smoke Inhalation Injury | 1 | 2016 | 28 | 0.500 |
Why?
| | Tranexamic Acid | 3 | 2023 | 40 | 0.490 |
Why?
| | Altitude | 1 | 2020 | 485 | 0.490 |
Why?
| | Out-of-Hospital Cardiac Arrest | 1 | 2016 | 72 | 0.490 |
Why?
| | Antifibrinolytic Agents | 3 | 2023 | 51 | 0.490 |
Why?
| | Tibia | 2 | 2014 | 178 | 0.480 |
Why?
| | Telemedicine | 2 | 2015 | 851 | 0.480 |
Why?
| | South Africa | 4 | 2024 | 217 | 0.480 |
Why?
| | Substance-Related Disorders | 4 | 2017 | 1069 | 0.480 |
Why?
| | Lipopolysaccharides | 1 | 2019 | 886 | 0.470 |
Why?
| | Acidosis, Lactic | 1 | 2015 | 46 | 0.470 |
Why?
| | Adolescent | 25 | 2021 | 21382 | 0.460 |
Why?
| | Hematinics | 1 | 2015 | 22 | 0.460 |
Why?
| | Asphyxia | 1 | 2014 | 20 | 0.460 |
Why?
| | Diphenhydramine | 2 | 2015 | 37 | 0.450 |
Why?
| | Electrocardiography | 5 | 2012 | 629 | 0.450 |
Why?
| | Patient Simulation | 1 | 2014 | 35 | 0.450 |
Why?
| | Efficiency | 1 | 2015 | 98 | 0.440 |
Why?
| | Solvents | 2 | 2004 | 108 | 0.430 |
Why?
| | Tracheotomy | 1 | 2014 | 23 | 0.430 |
Why?
| | Awards and Prizes | 1 | 2015 | 67 | 0.430 |
Why?
| | Self Report | 2 | 2017 | 822 | 0.430 |
Why?
| | Exsanguination | 1 | 2013 | 19 | 0.430 |
Why?
| | Anemia | 1 | 2015 | 170 | 0.430 |
Why?
| | Texas | 5 | 2017 | 243 | 0.410 |
Why?
| | Tracheostomy | 1 | 2015 | 132 | 0.410 |
Why?
| | Dietary Supplements | 1 | 2017 | 559 | 0.410 |
Why?
| | Practice Patterns, Physicians' | 3 | 2020 | 1301 | 0.410 |
Why?
| | Superior Mesenteric Artery Syndrome | 1 | 2013 | 6 | 0.410 |
Why?
| | Mobile Health Units | 2 | 2012 | 21 | 0.400 |
Why?
| | Burns, Chemical | 2 | 2017 | 32 | 0.400 |
Why?
| | Incidence | 10 | 2022 | 2792 | 0.400 |
Why?
| | Glyoxylates | 2 | 2023 | 10 | 0.400 |
Why?
| | Chemical and Drug Induced Liver Injury | 1 | 2014 | 136 | 0.390 |
Why?
| | Forensic Medicine | 1 | 2012 | 18 | 0.390 |
Why?
| | Aerospace Medicine | 3 | 2017 | 29 | 0.390 |
Why?
| | Viperidae | 2 | 2011 | 7 | 0.390 |
Why?
| | Methanol | 2 | 2016 | 38 | 0.390 |
Why?
| | Seizures | 3 | 2013 | 425 | 0.390 |
Why?
| | Chi-Square Distribution | 4 | 2019 | 530 | 0.380 |
Why?
| | Vitamin B 12 | 1 | 2012 | 128 | 0.370 |
Why?
| | Hyperalgesia | 1 | 2012 | 123 | 0.360 |
Why?
| | Metformin | 1 | 2015 | 330 | 0.360 |
Why?
| | Education, Medical | 1 | 2014 | 260 | 0.360 |
Why?
| | Renal Dialysis | 1 | 2015 | 435 | 0.360 |
Why?
| | Gas Chromatography-Mass Spectrometry | 3 | 2020 | 132 | 0.360 |
Why?
| | Fires | 1 | 2012 | 89 | 0.360 |
Why?
| | Bone and Bones | 1 | 2014 | 316 | 0.360 |
Why?
| | Mass Screening | 2 | 2018 | 1267 | 0.350 |
Why?
| | Gait | 1 | 2014 | 296 | 0.350 |
Why?
| | Fluid Therapy | 3 | 2019 | 147 | 0.350 |
Why?
| | Injections, Intravenous | 5 | 2018 | 207 | 0.350 |
Why?
| | Extremities | 2 | 2022 | 129 | 0.350 |
Why?
| | Referral and Consultation | 1 | 2016 | 780 | 0.350 |
Why?
| | Blood Component Transfusion | 2 | 2024 | 84 | 0.340 |
Why?
| | Survival Rate | 6 | 2018 | 1963 | 0.340 |
Why?
| | Antiviral Agents | 1 | 2016 | 739 | 0.340 |
Why?
| | Waiting Lists | 1 | 2012 | 262 | 0.330 |
Why?
| | Lung | 2 | 2020 | 4062 | 0.330 |
Why?
| | Influenza, Human | 1 | 2016 | 618 | 0.330 |
Why?
| | Medical Records | 2 | 2021 | 174 | 0.330 |
Why?
| | Thiocyanates | 5 | 2024 | 31 | 0.320 |
Why?
| | Surveys and Questionnaires | 9 | 2025 | 5742 | 0.310 |
Why?
| | Prescription Drug Misuse | 4 | 2020 | 40 | 0.300 |
Why?
| | Survival Analysis | 4 | 2021 | 1321 | 0.300 |
Why?
| | Immunoglobulin Fragments | 1 | 2008 | 12 | 0.300 |
Why?
| | Guideline Adherence | 4 | 2023 | 546 | 0.300 |
Why?
| | Omeprazole | 1 | 2008 | 7 | 0.290 |
Why?
| | Vascular Resistance | 3 | 2015 | 372 | 0.290 |
Why?
| | Rhabdomyolysis | 1 | 2008 | 21 | 0.290 |
Why?
| | Immunoglobulin Fab Fragments | 2 | 2008 | 59 | 0.280 |
Why?
| | Hydrothorax | 1 | 2007 | 3 | 0.280 |
Why?
| | Hyponatremia | 1 | 2008 | 42 | 0.280 |
Why?
| | Coma | 2 | 2022 | 32 | 0.280 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2016 | 1320 | 0.280 |
Why?
| | Drug Therapy, Combination | 4 | 2019 | 1062 | 0.280 |
Why?
| | Scalp | 1 | 2007 | 36 | 0.270 |
Why?
| | Video Recording | 2 | 2025 | 180 | 0.270 |
Why?
| | Physicians | 5 | 2019 | 907 | 0.270 |
Why?
| | Phosphorus | 1 | 2007 | 97 | 0.270 |
Why?
| | Proton Pump Inhibitors | 1 | 2008 | 109 | 0.270 |
Why?
| | Psoas Abscess | 1 | 2006 | 2 | 0.270 |
Why?
| | Practice Guidelines as Topic | 2 | 2017 | 1571 | 0.270 |
Why?
| | Methicillin Resistance | 1 | 2006 | 18 | 0.260 |
Why?
| | Delirium | 1 | 2008 | 89 | 0.260 |
Why?
| | Formates | 1 | 2006 | 13 | 0.260 |
Why?
| | Linear Models | 3 | 2015 | 846 | 0.260 |
Why?
| | Metabolomics | 2 | 2025 | 678 | 0.260 |
Why?
| | Infant | 10 | 2021 | 9398 | 0.260 |
Why?
| | Explosions | 2 | 2021 | 9 | 0.260 |
Why?
| | Hypothermia | 2 | 2024 | 36 | 0.260 |
Why?
| | Blindness | 1 | 2006 | 38 | 0.250 |
Why?
| | Models, Animal | 3 | 2024 | 384 | 0.250 |
Why?
| | Poisons | 2 | 2019 | 23 | 0.250 |
Why?
| | Cohort Studies | 6 | 2023 | 5701 | 0.250 |
Why?
| | Toxicity Tests, Acute | 2 | 2018 | 8 | 0.250 |
Why?
| | Hypoglycemic Agents | 1 | 2015 | 1283 | 0.250 |
Why?
| | Kaplan-Meier Estimate | 2 | 2018 | 888 | 0.250 |
Why?
| | Clinical Competence | 3 | 2025 | 1094 | 0.250 |
Why?
| | Rabbits | 5 | 2021 | 792 | 0.250 |
Why?
| | Child, Preschool | 10 | 2021 | 11000 | 0.250 |
Why?
| | Fentanyl | 2 | 2017 | 94 | 0.240 |
Why?
| | Tertiary Care Centers | 2 | 2017 | 159 | 0.240 |
Why?
| | Zebrafish | 2 | 2022 | 495 | 0.240 |
Why?
| | Intention | 1 | 2007 | 169 | 0.240 |
Why?
| | Administration, Intranasal | 1 | 2025 | 89 | 0.240 |
Why?
| | Psychotropic Drugs | 1 | 2005 | 68 | 0.240 |
Why?
| | Biomarkers | 4 | 2024 | 4144 | 0.240 |
Why?
| | Wound Infection | 1 | 2025 | 32 | 0.240 |
Why?
| | Hospitals | 2 | 2022 | 685 | 0.230 |
Why?
| | Cocaine | 1 | 2007 | 166 | 0.230 |
Why?
| | Travel | 2 | 2016 | 130 | 0.230 |
Why?
| | Crotalid Venoms | 2 | 2011 | 31 | 0.230 |
Why?
| | Fat Emulsions, Intravenous | 2 | 2015 | 30 | 0.230 |
Why?
| | Diagnosis, Differential | 4 | 2015 | 1481 | 0.230 |
Why?
| | Double-Blind Method | 2 | 2015 | 1981 | 0.230 |
Why?
| | Cannabis | 1 | 2012 | 487 | 0.220 |
Why?
| | Feedback | 1 | 2025 | 173 | 0.220 |
Why?
| | Suicide, Attempted | 4 | 2015 | 373 | 0.220 |
Why?
| | Hydrocarbons | 1 | 2004 | 31 | 0.220 |
Why?
| | Terpenes | 1 | 2004 | 22 | 0.220 |
Why?
| | Echocardiography | 2 | 2018 | 642 | 0.220 |
Why?
| | Risk | 2 | 2018 | 908 | 0.220 |
Why?
| | Antibiotic Prophylaxis | 1 | 2025 | 115 | 0.220 |
Why?
| | Oxidative Phosphorylation | 1 | 2025 | 193 | 0.220 |
Why?
| | Equipment Reuse | 1 | 2024 | 16 | 0.220 |
Why?
| | Limit of Detection | 3 | 2012 | 85 | 0.220 |
Why?
| | Child | 15 | 2021 | 21822 | 0.220 |
Why?
| | Research Design | 3 | 2015 | 1127 | 0.210 |
Why?
| | Crotalus | 1 | 2004 | 26 | 0.210 |
Why?
| | Cross-Sectional Studies | 3 | 2024 | 5423 | 0.210 |
Why?
| | Pilot Projects | 4 | 2023 | 1692 | 0.210 |
Why?
| | Animal Experimentation | 1 | 2003 | 6 | 0.210 |
Why?
| | Neck Injuries | 1 | 2023 | 21 | 0.210 |
Why?
| | Noninvasive Ventilation | 1 | 2024 | 51 | 0.210 |
Why?
| | Glycolysis | 1 | 2025 | 319 | 0.210 |
Why?
| | Glasgow Coma Scale | 1 | 2004 | 184 | 0.210 |
Why?
| | Shock, Traumatic | 1 | 2023 | 14 | 0.200 |
Why?
| | Mycophenolic Acid | 1 | 2004 | 117 | 0.200 |
Why?
| | Tomography, X-Ray Computed | 1 | 2013 | 2667 | 0.200 |
Why?
| | Ventilators, Mechanical | 1 | 2023 | 58 | 0.190 |
Why?
| | Hypoxia | 3 | 2025 | 1112 | 0.190 |
Why?
| | Plant Extracts | 1 | 2004 | 202 | 0.190 |
Why?
| | Staphylococcus aureus | 1 | 2006 | 449 | 0.190 |
Why?
| | Fibrinolysis | 1 | 2023 | 143 | 0.190 |
Why?
| | Staphylococcal Infections | 1 | 2006 | 399 | 0.190 |
Why?
| | Seasons | 1 | 2024 | 544 | 0.180 |
Why?
| | Follow-Up Studies | 5 | 2017 | 5106 | 0.180 |
Why?
| | Toxicokinetics | 2 | 2018 | 9 | 0.180 |
Why?
| | Memory | 1 | 2023 | 248 | 0.180 |
Why?
| | Emergency Responders | 1 | 2021 | 36 | 0.170 |
Why?
| | Heart Rate | 3 | 2015 | 820 | 0.170 |
Why?
| | Feasibility Studies | 2 | 2023 | 951 | 0.170 |
Why?
| | Lactates | 2 | 2012 | 85 | 0.170 |
Why?
| | Soil Pollutants | 1 | 2020 | 18 | 0.170 |
Why?
| | Personal Protective Equipment | 1 | 2021 | 52 | 0.170 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2023 | 188 | 0.170 |
Why?
| | Consensus | 3 | 2021 | 678 | 0.170 |
Why?
| | Guidelines as Topic | 3 | 2017 | 275 | 0.170 |
Why?
| | Disulfides | 1 | 2020 | 107 | 0.170 |
Why?
| | Prescription Drug Monitoring Programs | 1 | 2020 | 14 | 0.170 |
Why?
| | Inhalation Exposure | 1 | 2020 | 105 | 0.160 |
Why?
| | Patient Outcome Assessment | 2 | 2021 | 131 | 0.160 |
Why?
| | Wounds, Nonpenetrating | 2 | 2021 | 276 | 0.160 |
Why?
| | Endovascular Procedures | 1 | 2024 | 311 | 0.160 |
Why?
| | Thiazoles | 2 | 2024 | 123 | 0.160 |
Why?
| | Agkistrodon | 1 | 2019 | 5 | 0.160 |
Why?
| | Brain Concussion | 2 | 2023 | 573 | 0.160 |
Why?
| | Calcium | 2 | 2023 | 1197 | 0.160 |
Why?
| | Brain Injuries | 2 | 2023 | 494 | 0.160 |
Why?
| | Ketorolac | 1 | 2019 | 20 | 0.150 |
Why?
| | Haloperidol | 1 | 2019 | 34 | 0.150 |
Why?
| | Gases | 1 | 2019 | 48 | 0.150 |
Why?
| | Adrenergic Agonists | 1 | 2018 | 5 | 0.150 |
Why?
| | Aged | 8 | 2024 | 23794 | 0.150 |
Why?
| | Terrorism | 1 | 2018 | 24 | 0.150 |
Why?
| | Sodium Cyanide | 1 | 2018 | 1 | 0.150 |
Why?
| | Harm Reduction | 1 | 2019 | 38 | 0.150 |
Why?
| | Blood Circulation | 1 | 2018 | 41 | 0.150 |
Why?
| | Documentation | 1 | 2020 | 191 | 0.150 |
Why?
| | Immunosuppressive Agents | 1 | 2004 | 889 | 0.150 |
Why?
| | Pyruvate Dehydrogenase Complex | 1 | 2018 | 9 | 0.150 |
Why?
| | Logistic Models | 3 | 2024 | 2067 | 0.150 |
Why?
| | Tympanic Membrane Perforation | 2 | 2009 | 17 | 0.150 |
Why?
| | Reproducibility of Results | 3 | 2013 | 3264 | 0.140 |
Why?
| | Cholinesterase Inhibitors | 1 | 2018 | 30 | 0.140 |
Why?
| | Torso | 1 | 2018 | 33 | 0.140 |
Why?
| | Dextropropoxyphene | 1 | 2017 | 3 | 0.140 |
Why?
| | War Exposure | 1 | 2018 | 12 | 0.140 |
Why?
| | Saliva | 1 | 2019 | 242 | 0.140 |
Why?
| | Vascular Access Devices | 1 | 2018 | 26 | 0.140 |
Why?
| | Tramadol | 1 | 2017 | 14 | 0.140 |
Why?
| | Methemoglobinemia | 1 | 2017 | 13 | 0.140 |
Why?
| | Burns, Inhalation | 1 | 2017 | 9 | 0.140 |
Why?
| | Drug Prescriptions | 2 | 2020 | 243 | 0.140 |
Why?
| | Blood Proteins | 1 | 2019 | 252 | 0.140 |
Why?
| | Analysis of Variance | 2 | 2017 | 1316 | 0.140 |
Why?
| | Tidal Volume | 1 | 2018 | 86 | 0.140 |
Why?
| | Solid Phase Extraction | 2 | 2019 | 25 | 0.140 |
Why?
| | Cognition | 1 | 2025 | 1146 | 0.140 |
Why?
| | Rescue Work | 1 | 2017 | 9 | 0.130 |
Why?
| | Acidosis | 2 | 2009 | 101 | 0.130 |
Why?
| | Statistics, Nonparametric | 1 | 2018 | 431 | 0.130 |
Why?
| | Disease Management | 3 | 2017 | 624 | 0.130 |
Why?
| | Hemoglobins | 2 | 2018 | 353 | 0.130 |
Why?
| | Dextromethorphan | 1 | 2016 | 18 | 0.130 |
Why?
| | Blood Coagulation | 1 | 2018 | 255 | 0.130 |
Why?
| | Headache | 1 | 2017 | 147 | 0.130 |
Why?
| | Sodium Chloride | 1 | 2017 | 142 | 0.130 |
Why?
| | Antacids | 1 | 2016 | 16 | 0.130 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 2 | 2015 | 413 | 0.130 |
Why?
| | Epidemics | 1 | 2018 | 89 | 0.130 |
Why?
| | Musculoskeletal Diseases | 1 | 2017 | 77 | 0.130 |
Why?
| | Telephone | 1 | 2017 | 170 | 0.130 |
Why?
| | Shock, Septic | 1 | 2019 | 219 | 0.130 |
Why?
| | Educational Status | 2 | 2016 | 470 | 0.130 |
Why?
| | Combined Modality Therapy | 2 | 2017 | 1231 | 0.130 |
Why?
| | Medical Errors | 1 | 2017 | 112 | 0.130 |
Why?
| | Clinical Protocols | 1 | 2018 | 267 | 0.130 |
Why?
| | Pharmacy Service, Hospital | 1 | 2017 | 90 | 0.130 |
Why?
| | Antimetabolites, Antineoplastic | 1 | 2016 | 94 | 0.130 |
Why?
| | Inpatients | 1 | 2020 | 496 | 0.130 |
Why?
| | Decision Trees | 1 | 2016 | 93 | 0.120 |
Why?
| | Point-of-Care Testing | 1 | 2016 | 32 | 0.120 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2019 | 350 | 0.120 |
Why?
| | Algorithms | 2 | 2016 | 1689 | 0.120 |
Why?
| | Heart Diseases | 1 | 2019 | 346 | 0.120 |
Why?
| | Prescription Drug Diversion | 1 | 2015 | 12 | 0.120 |
Why?
| | Massachusetts | 1 | 2016 | 171 | 0.120 |
Why?
| | Prognosis | 2 | 2019 | 4013 | 0.120 |
Why?
| | Radiation Injuries | 1 | 2017 | 145 | 0.120 |
Why?
| | Gastrointestinal Diseases | 1 | 2017 | 209 | 0.120 |
Why?
| | Drug Utilization Review | 1 | 2015 | 57 | 0.120 |
Why?
| | Drug Costs | 1 | 2016 | 106 | 0.120 |
Why?
| | Sepsis | 1 | 2021 | 614 | 0.120 |
Why?
| | Benzodiazepines | 1 | 2016 | 153 | 0.120 |
Why?
| | Disaster Planning | 1 | 2016 | 89 | 0.120 |
Why?
| | Methotrexate | 1 | 2016 | 260 | 0.120 |
Why?
| | Randomized Controlled Trials as Topic | 4 | 2023 | 1462 | 0.120 |
Why?
| | Angiography | 2 | 2013 | 207 | 0.120 |
Why?
| | Zebrafish Proteins | 1 | 2018 | 286 | 0.120 |
Why?
| | Breast Neoplasms | 1 | 2007 | 2234 | 0.120 |
Why?
| | Anti-Bacterial Agents | 1 | 2025 | 1798 | 0.120 |
Why?
| | Equipment Design | 2 | 2024 | 521 | 0.120 |
Why?
| | Phenols | 1 | 2015 | 97 | 0.110 |
Why?
| | Proteome | 1 | 2019 | 472 | 0.110 |
Why?
| | Proportional Hazards Models | 1 | 2018 | 1261 | 0.110 |
Why?
| | Metabolome | 1 | 2018 | 350 | 0.110 |
Why?
| | Practice Patterns, Nurses' | 1 | 2014 | 18 | 0.110 |
Why?
| | Vitamin B Complex | 1 | 2014 | 43 | 0.110 |
Why?
| | Shock | 2 | 2012 | 95 | 0.110 |
Why?
| | Thyroid Cartilage | 1 | 2014 | 4 | 0.110 |
Why?
| | Health Services Research | 1 | 2016 | 399 | 0.110 |
Why?
| | Aspartate Aminotransferases | 1 | 2014 | 90 | 0.110 |
Why?
| | Teaching Rounds | 1 | 2015 | 67 | 0.110 |
Why?
| | Liver Function Tests | 1 | 2014 | 114 | 0.110 |
Why?
| | Nurses | 1 | 2016 | 176 | 0.110 |
Why?
| | Societies, Medical | 1 | 2018 | 816 | 0.110 |
Why?
| | Anesthesia, General | 1 | 2014 | 71 | 0.110 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2016 | 250 | 0.110 |
Why?
| | Ketoglutaric Acids | 1 | 2013 | 16 | 0.110 |
Why?
| | Mortality | 1 | 2016 | 359 | 0.100 |
Why?
| | Anesthetics | 1 | 2014 | 81 | 0.100 |
Why?
| | Length of Stay | 2 | 2016 | 1205 | 0.100 |
Why?
| | Alanine Transaminase | 1 | 2014 | 157 | 0.100 |
Why?
| | Mentors | 1 | 2015 | 200 | 0.100 |
Why?
| | Ischemia | 2 | 2014 | 407 | 0.100 |
Why?
| | Aged, 80 and over | 3 | 2016 | 7585 | 0.100 |
Why?
| | Central Nervous System Stimulants | 1 | 2015 | 161 | 0.100 |
Why?
| | Necrosis | 1 | 2014 | 245 | 0.100 |
Why?
| | Academic Medical Centers | 1 | 2016 | 504 | 0.100 |
Why?
| | Drug Combinations | 1 | 2014 | 343 | 0.100 |
Why?
| | Health Surveys | 1 | 2015 | 513 | 0.100 |
Why?
| | Proteomics | 1 | 2019 | 1109 | 0.100 |
Why?
| | Common Cold | 1 | 2012 | 13 | 0.100 |
Why?
| | Tertiary Healthcare | 1 | 2012 | 33 | 0.100 |
Why?
| | Drug Stability | 1 | 2013 | 167 | 0.100 |
Why?
| | Data Collection | 1 | 2015 | 668 | 0.100 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2018 | 2052 | 0.100 |
Why?
| | Nitriles | 1 | 2013 | 172 | 0.100 |
Why?
| | Respiratory System Agents | 1 | 2012 | 22 | 0.100 |
Why?
| | Chromatography, Thin Layer | 1 | 2012 | 26 | 0.090 |
Why?
| | Cadaver | 2 | 2024 | 296 | 0.090 |
Why?
| | Basilar Artery | 1 | 2012 | 6 | 0.090 |
Why?
| | Blood Chemical Analysis | 1 | 2012 | 99 | 0.090 |
Why?
| | Cues | 1 | 2014 | 313 | 0.090 |
Why?
| | Safety | 2 | 2013 | 338 | 0.090 |
Why?
| | Nonprescription Drugs | 1 | 2012 | 63 | 0.090 |
Why?
| | Triage | 2 | 2017 | 221 | 0.090 |
Why?
| | Fever | 1 | 2013 | 306 | 0.090 |
Why?
| | Cough | 1 | 2012 | 122 | 0.090 |
Why?
| | Burn Units | 2 | 2025 | 48 | 0.090 |
Why?
| | Arterial Occlusive Diseases | 1 | 2012 | 80 | 0.090 |
Why?
| | Risk Assessment | 2 | 2018 | 3432 | 0.090 |
Why?
| | Abbreviated Injury Scale | 2 | 2021 | 22 | 0.090 |
Why?
| | Femur | 1 | 2013 | 254 | 0.090 |
Why?
| | Health Care Surveys | 1 | 2012 | 562 | 0.080 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2012 | 560 | 0.080 |
Why?
| | Patient Satisfaction | 1 | 2015 | 656 | 0.080 |
Why?
| | Drug Administration Routes | 1 | 2010 | 38 | 0.080 |
Why?
| | Needlestick Injuries | 1 | 2010 | 4 | 0.080 |
Why?
| | Sleep Stages | 1 | 2010 | 47 | 0.080 |
Why?
| | Tissue Plasminogen Activator | 1 | 2012 | 223 | 0.080 |
Why?
| | Pain, Postoperative | 1 | 2012 | 265 | 0.080 |
Why?
| | Nausea | 1 | 2010 | 111 | 0.080 |
Why?
| | Mice | 4 | 2023 | 17757 | 0.080 |
Why?
| | Vomiting | 1 | 2010 | 130 | 0.080 |
Why?
| | Manikins | 1 | 2009 | 28 | 0.080 |
Why?
| | Fibrinolytic Agents | 1 | 2012 | 270 | 0.080 |
Why?
| | Allied Health Personnel | 1 | 2009 | 46 | 0.080 |
Why?
| | Curriculum | 1 | 2015 | 976 | 0.080 |
Why?
| | Anaphylaxis | 1 | 2010 | 105 | 0.070 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2017 | 842 | 0.070 |
Why?
| | Mental Health | 1 | 2015 | 716 | 0.070 |
Why?
| | Inservice Training | 1 | 2009 | 114 | 0.070 |
Why?
| | Sensitivity and Specificity | 1 | 2013 | 1935 | 0.070 |
Why?
| | Patient Care Team | 1 | 2013 | 626 | 0.070 |
Why?
| | Thoracostomy | 1 | 2007 | 17 | 0.070 |
Why?
| | Electronic Health Records | 1 | 2015 | 1046 | 0.070 |
Why?
| | Dermis | 1 | 2007 | 33 | 0.070 |
Why?
| | Unconsciousness | 1 | 2007 | 19 | 0.070 |
Why?
| | Arrhythmias, Cardiac | 1 | 2010 | 333 | 0.070 |
Why?
| | Decision Support Systems, Clinical | 2 | 2021 | 223 | 0.070 |
Why?
| | Spectrum Analysis | 2 | 2018 | 91 | 0.070 |
Why?
| | Primary Health Care | 2 | 2020 | 1721 | 0.070 |
Why?
| | Risk Factors | 5 | 2017 | 10326 | 0.070 |
Why?
| | Fatal Outcome | 1 | 2007 | 303 | 0.070 |
Why?
| | Decision Support Techniques | 1 | 2011 | 418 | 0.060 |
Why?
| | Sodium Channels | 1 | 2007 | 65 | 0.060 |
Why?
| | Severity of Illness Index | 1 | 2014 | 2822 | 0.060 |
Why?
| | Vasopressins | 1 | 2006 | 64 | 0.060 |
Why?
| | Atomoxetine Hydrochloride | 1 | 2005 | 6 | 0.060 |
Why?
| | Propylamines | 1 | 2005 | 10 | 0.060 |
Why?
| | Death, Sudden | 1 | 2005 | 24 | 0.060 |
Why?
| | Vasoconstrictor Agents | 1 | 2006 | 139 | 0.060 |
Why?
| | Oxygen Consumption | 2 | 2019 | 695 | 0.060 |
Why?
| | Valproic Acid | 1 | 2005 | 47 | 0.060 |
Why?
| | Treatment Failure | 1 | 2007 | 354 | 0.060 |
Why?
| | Analgesics, Non-Narcotic | 1 | 2007 | 124 | 0.060 |
Why?
| | Vasospasm, Intracranial | 1 | 2005 | 17 | 0.060 |
Why?
| | Subarachnoid Hemorrhage | 1 | 2005 | 66 | 0.060 |
Why?
| | Health Services Accessibility | 1 | 2012 | 978 | 0.060 |
Why?
| | Dimethylformamide | 1 | 2004 | 1 | 0.060 |
Why?
| | Kerosene | 1 | 2004 | 1 | 0.060 |
Why?
| | Hexanones | 1 | 2004 | 2 | 0.060 |
Why?
| | Hexanes | 1 | 2004 | 4 | 0.060 |
Why?
| | Administration, Inhalation | 1 | 2006 | 683 | 0.060 |
Why?
| | Cyclohexenes | 1 | 2004 | 6 | 0.060 |
Why?
| | Alkanes | 1 | 2004 | 13 | 0.060 |
Why?
| | Forensic Toxicology | 1 | 2024 | 2 | 0.060 |
Why?
| | Dimethyl Sulfoxide | 1 | 2004 | 41 | 0.060 |
Why?
| | Community-Acquired Infections | 1 | 2006 | 169 | 0.060 |
Why?
| | Oleic Acid | 1 | 2004 | 40 | 0.060 |
Why?
| | Linoleic Acid | 1 | 2004 | 43 | 0.060 |
Why?
| | Electric Power Supplies | 1 | 2024 | 51 | 0.050 |
Why?
| | Catheters | 1 | 2024 | 72 | 0.050 |
Why?
| | Charcoal | 1 | 2004 | 25 | 0.050 |
Why?
| | Sorbitol | 1 | 2023 | 14 | 0.050 |
Why?
| | Blood Cell Count | 1 | 2004 | 55 | 0.050 |
Why?
| | Parents | 1 | 2012 | 1340 | 0.050 |
Why?
| | Half-Life | 2 | 2014 | 164 | 0.050 |
Why?
| | Masks | 1 | 2024 | 63 | 0.050 |
Why?
| | Anticonvulsants | 1 | 2005 | 215 | 0.050 |
Why?
| | Lupus Nephritis | 1 | 2004 | 63 | 0.050 |
Why?
| | Fibrin | 1 | 2004 | 81 | 0.050 |
Why?
| | Rats | 2 | 2022 | 5639 | 0.050 |
Why?
| | Observer Variation | 1 | 2004 | 341 | 0.050 |
Why?
| | Ambulances | 1 | 2023 | 51 | 0.050 |
Why?
| | Fibrinogen | 1 | 2004 | 167 | 0.050 |
Why?
| | Cross-Over Studies | 1 | 2025 | 562 | 0.050 |
Why?
| | Calcium, Dietary | 1 | 2023 | 57 | 0.050 |
Why?
| | Specimen Handling | 1 | 2024 | 181 | 0.050 |
Why?
| | Hemostasis | 1 | 2023 | 82 | 0.050 |
Why?
| | Chromatography, High Pressure Liquid | 2 | 2019 | 597 | 0.050 |
Why?
| | Depressive Disorder | 1 | 2005 | 379 | 0.050 |
Why?
| | Intracranial Hemorrhages | 1 | 2023 | 85 | 0.050 |
Why?
| | Pyruvic Acid | 1 | 2022 | 53 | 0.050 |
Why?
| | Armed Conflicts | 1 | 2021 | 10 | 0.050 |
Why?
| | Meta-Analysis as Topic | 1 | 2023 | 186 | 0.050 |
Why?
| | Blood Coagulation Disorders | 1 | 2023 | 172 | 0.050 |
Why?
| | Bandages | 1 | 2021 | 37 | 0.050 |
Why?
| | Cricetulus | 1 | 2021 | 109 | 0.050 |
Why?
| | CHO Cells | 1 | 2021 | 161 | 0.040 |
Why?
| | Aviation | 1 | 2021 | 8 | 0.040 |
Why?
| | Fumigation | 1 | 2020 | 3 | 0.040 |
Why?
| | Cricetinae | 1 | 2021 | 289 | 0.040 |
Why?
| | Sheep | 1 | 2004 | 856 | 0.040 |
Why?
| | Temperature | 1 | 2024 | 675 | 0.040 |
Why?
| | Hydrazines | 1 | 2021 | 35 | 0.040 |
Why?
| | Hypertension | 1 | 2010 | 1284 | 0.040 |
Why?
| | Rats, Sprague-Dawley | 2 | 2018 | 2486 | 0.040 |
Why?
| | Oximetry | 1 | 2021 | 96 | 0.040 |
Why?
| | Hospital Mortality | 1 | 2025 | 901 | 0.040 |
Why?
| | Age Factors | 2 | 2019 | 3284 | 0.040 |
Why?
| | Multicenter Studies as Topic | 1 | 2021 | 308 | 0.040 |
Why?
| | Pesticides | 1 | 2020 | 62 | 0.040 |
Why?
| | Hemolysis | 1 | 2022 | 206 | 0.040 |
Why?
| | Mammals | 1 | 2022 | 283 | 0.040 |
Why?
| | Intersectoral Collaboration | 1 | 2020 | 60 | 0.040 |
Why?
| | Myocardial Infarction | 1 | 2007 | 1041 | 0.040 |
Why?
| | Intensive Care Units | 1 | 2025 | 800 | 0.040 |
Why?
| | Quality Improvement | 2 | 2021 | 1163 | 0.040 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2019 | 180 | 0.040 |
Why?
| | Regression Analysis | 1 | 2021 | 1022 | 0.040 |
Why?
| | Directive Counseling | 1 | 2019 | 46 | 0.040 |
Why?
| | Cholinesterase Reactivators | 1 | 2018 | 1 | 0.040 |
Why?
| | Organophosphate Poisoning | 1 | 2018 | 1 | 0.040 |
Why?
| | Phosphorylation | 1 | 2023 | 1758 | 0.040 |
Why?
| | Electron Transport Complex IV | 1 | 2018 | 60 | 0.040 |
Why?
| | North America | 1 | 2019 | 312 | 0.040 |
Why?
| | Drug Storage | 1 | 2018 | 57 | 0.040 |
Why?
| | Multivariate Analysis | 1 | 2021 | 1507 | 0.040 |
Why?
| | Catheterization, Peripheral | 1 | 2019 | 109 | 0.030 |
Why?
| | Infant, Newborn | 2 | 2021 | 6033 | 0.030 |
Why?
| | Hospitalization | 2 | 2019 | 2183 | 0.030 |
Why?
| | Hippocampus | 1 | 2023 | 894 | 0.030 |
Why?
| | Resource Allocation | 1 | 2018 | 52 | 0.030 |
Why?
| | Multiple Trauma | 1 | 2018 | 100 | 0.030 |
Why?
| | Antipsychotic Agents | 1 | 2019 | 193 | 0.030 |
Why?
| | Peptides | 1 | 2023 | 980 | 0.030 |
Why?
| | Chemical Warfare Agents | 1 | 2018 | 114 | 0.030 |
Why?
| | Carbon Dioxide | 1 | 2018 | 267 | 0.030 |
Why?
| | United States Department of Veterans Affairs | 1 | 2020 | 674 | 0.030 |
Why?
| | Advisory Committees | 1 | 2016 | 219 | 0.030 |
Why?
| | Disasters | 1 | 2016 | 98 | 0.030 |
Why?
| | Patient Education as Topic | 1 | 2020 | 761 | 0.030 |
Why?
| | Delayed-Action Preparations | 1 | 2015 | 180 | 0.030 |
Why?
| | Oxidation-Reduction | 1 | 2018 | 1059 | 0.030 |
Why?
| | Inactivation, Metabolic | 1 | 2014 | 11 | 0.030 |
Why?
| | Recovery of Function | 1 | 2018 | 652 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2019 | 2022 | 0.030 |
Why?
| | Neurons | 1 | 2023 | 1587 | 0.030 |
Why?
| | Injections, Subcutaneous | 1 | 2014 | 154 | 0.030 |
Why?
| | Drug Approval | 1 | 2014 | 87 | 0.030 |
Why?
| | Eating | 1 | 2016 | 379 | 0.030 |
Why?
| | Thiazolidines | 1 | 2013 | 9 | 0.030 |
Why?
| | Pharmacokinetics | 1 | 2013 | 29 | 0.030 |
Why?
| | Indicators and Reagents | 1 | 2013 | 106 | 0.030 |
Why?
| | Qualitative Research | 1 | 2020 | 1366 | 0.030 |
Why?
| | Isotonic Solutions | 1 | 2013 | 38 | 0.030 |
Why?
| | Species Specificity | 1 | 2014 | 586 | 0.020 |
Why?
| | Teaching | 1 | 2015 | 224 | 0.020 |
Why?
| | Traumatology | 1 | 2012 | 26 | 0.020 |
Why?
| | Critical Care Nursing | 1 | 2013 | 36 | 0.020 |
Why?
| | Drug Monitoring | 1 | 2014 | 218 | 0.020 |
Why?
| | Quality Control | 1 | 2012 | 171 | 0.020 |
Why?
| | Educational Measurement | 1 | 2015 | 281 | 0.020 |
Why?
| | Socioeconomic Factors | 1 | 2017 | 1282 | 0.020 |
Why?
| | Infusions, Intra-Arterial | 1 | 2012 | 59 | 0.020 |
Why?
| | Organizational Innovation | 1 | 2012 | 138 | 0.020 |
Why?
| | Arginine | 1 | 2013 | 271 | 0.020 |
Why?
| | Arterial Pressure | 1 | 2012 | 126 | 0.020 |
Why?
| | United States Food and Drug Administration | 1 | 2012 | 208 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2019 | 3540 | 0.020 |
Why?
| | Erythrocytes | 1 | 2016 | 699 | 0.020 |
Why?
| | Acute Coronary Syndrome | 1 | 2014 | 275 | 0.020 |
Why?
| | Fingers | 1 | 2010 | 88 | 0.020 |
Why?
| | Explosive Agents | 1 | 2009 | 6 | 0.020 |
Why?
| | Injections | 1 | 2010 | 183 | 0.020 |
Why?
| | Inflammation | 1 | 2020 | 2835 | 0.020 |
Why?
| | Delphi Technique | 1 | 2011 | 273 | 0.020 |
Why?
| | Thrombosis | 1 | 2013 | 366 | 0.020 |
Why?
| | Comorbidity | 1 | 2013 | 1614 | 0.020 |
Why?
| | Vasodilator Agents | 1 | 2010 | 331 | 0.020 |
Why?
| | Pulse | 1 | 2006 | 23 | 0.020 |
Why?
| | Immunoassay | 1 | 2007 | 113 | 0.020 |
Why?
| | Coronary Circulation | 1 | 2006 | 140 | 0.020 |
Why?
| | Electric Countershock | 1 | 2006 | 107 | 0.020 |
Why?
| | Early Diagnosis | 1 | 2007 | 240 | 0.020 |
Why?
| | Haplorhini | 1 | 2005 | 52 | 0.010 |
Why?
| | Delivery of Health Care | 1 | 2012 | 934 | 0.010 |
Why?
| | Postoperative Complications | 1 | 2013 | 2639 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2012 | 3555 | 0.010 |
Why?
|
|
Bebarta's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|